Kapvay

Kapvay is a brand name of clonidine, approved by the FDA in the following formulation(s):

KAPVAY (clonidine hydrochloride - tablet, extended release; oral)

• 
  Manufacturer: SHIONOGI INC
  
  Approval date: September 28, 2010
  
  Strength(s): 0.1MG ^[RLD]

Has a generic version of Kapvay been approved?

No. There is currently no therapeutically equivalent version of Kapvay available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Kapvay. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Extended release clonidine formulation (tablet)
  Patent 5,869,100
  Issued: February 9, 1999
  Inventor(s): Horacek; H. Joseph
  A method of providing a patient needing clonidine with an extended dosage of clonidine over a prolonged period of time. Such method involves administering to the patient an oral dosage unit comprising a homogenous mixture of a therapeutically effective amount of clonidine, about 30 to about 70 percent by weight of one or more cellulose ethers such as hydroxypropyl methylcellulose, and about 30 to about 70 percent by weight of an inert substance such as cornstarch. The oral dosage unit may be contained in a gelatin capsule or in the form of a tablet.
  
  Patent expiration dates:
  
  
  • October 13, 2013
    
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • September 28, 2013 - NEW PRODUCT
  
  

See also...

• Kapvay Consumer Information (Drugs.com)
• Kapvay Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Kapvay Consumer Information (Cerner Multum)
• Kapvay Advanced Consumer Information (Micromedex)
• Clonidine Consumer Information (Drugs.com)
• Clonidine Consumer Information (Wolters Kluwer)
• Clonidine Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Clonidine Patches Consumer Information (Wolters Kluwer)
• Clonidine Tablets Consumer Information (Wolters Kluwer)
• Clonidine Consumer Information (Cerner Multum)
• Clonidine transdermal Consumer Information (Cerner Multum)
• Clonidine Epidural Advanced Consumer Information (Micromedex)
• Clonidine Oral, Transdermal Advanced Consumer Information (Micromedex)
• Clonidine Transdermal Advanced Consumer Information (Micromedex)
• Clonidine AHFS DI Monographs (ASHP)